NGM Biopharmaceuticals, Inc. Profile Avatar - Palmy Investing

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an enginee…

Biotechnology
US, South San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

NGM Biopharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

NGM Biopharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of NGM Biopharmaceuticals, Inc..

End of NGM's Analysis
CIK: 1426332 CUSIP: 62921N105 ISIN: US62921N1054 LEI: - UEI: -
Secondary Listings
NGM has no secondary listings inside our databases.